Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-25 @ 6:54 PM
Study NCT ID:
NCT04752059
Status:
COMPLETED
Last Update Posted:
2023-05-12
First Post:
2021-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases
Sponsor:
Medical University of Vienna
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-26
First Submit QC Date:
None
Study First Post Date:
2021-02-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-10
Last Update Post Date:
2023-05-12
Last Update Post Date Type:
ACTUAL